Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurotransmitter biosynthetic enzymes are a broad class of enzymes responsible for catalyzing the chemical reactions that produce neurotransmitters from their precursors. These enzymes play a critical role in regulating the availability and balance of key signaling molecules such as dopamine, serotonin, acetylcholine, glutamate, GABA, norepinephrine, epinephrine, histamine, and others. Each major neurotransmitter has one or more dedicated biosynthetic enzymes that control its production within neurons: - **Tyrosine hydroxylase** is the rate-limiting enzyme for catecholamines like dopamine and norepinephrine. - **Tryptophan hydroxylase** initiates serotonin synthesis. - **Choline acetyltransferase** synthesizes acetylcholine. - **Glutaminase**, **glutamic acid decarboxylase**, and other amino acid-modifying enzymes generate glutamate and GABA. These enzymes are essential for normal brain function; their dysregulation is implicated in numerous neurological and psychiatric diseases including Parkinson’s disease (dopamine deficiency), depression (serotonin imbalance), schizophrenia (dopamine/serotonin dysregulation), epilepsy (GABA/glutamate imbalance), among others. Many drugs act directly or indirectly by modulating these enzymatic activities to restore proper neurotransmitter levels. However—“neurotransmitter biosynthetic enzymes” is not a single molecular target but rather an umbrella term covering many distinct proteins. For structured data purposes it is too broad; each individual enzyme should be considered separately with its own canonical name (“Tyrosine hydroxylase”, “Tryptophan hydroxylase”, etc.). Therefore: is_incorrect: true — The entry refers to a class/family rather than a specific molecular target. Structured information should be collected at the level of individual named enzymes.
Inhibition or enhancement of neurotransmitter production by modulating enzymatic activity in biosynthetic pathways
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotransmitter biosynthetic enzyme.